Market Data

This information is collected under the Access to Cannabis for Medical Purposes Regulations, which replaced the Marihuana for Medical Purposes Regulations on August 24, 2016.

Based on market data, there is overall sufficient supply of cannabis for medical purposes to meet the current needs of registered clients. 

Notice of reporting changes:

As part of a continual effort to improve data collection, Health Canada clarified reporting requirements for licensed producers in October 2016. Licensed producers have been asked to report on the amount of cannabis for medical purposes that they have released for sale to clients. This amount is to include only product that has been approved for sale to clients (e.g., tested and ready for sale), which may have been produced in either the current or a previous reporting period. As such, this amount is to exclude product that was produced during the current reporting period and not yet approved for sale (e.g., not yet tested and ready for sale).

This reporting change, beginning with data in Q3, will allow for a more accurate picture of the volume of supply that is available to registered clients; and, more consistent period-over-period analysis in the future. It also aligns more closely with the inventory tracking practices of the licensed producers. Note: the change does not allow for a direct comparison with previous reporting periods.

In Q3, Health Canada also began to report on the number of active registration certificates issued to persons that are authorized to produce a limited amount of cannabis for their own medical purposes, or who have been designated to produce for another person.

Cannabis for Medical Purposes (FY 2016-17) - Licensed Producers: Quarterly Data
  April 1, 2016 to June 30, 2016 (Q1) July 1, 2016 to September 30, 2016 (Q2) October 1, 2016 to December 31, 2016 (Q3) January 1, 2017 to March 31, 2017 (Q4)

Market Data Table 1 footnotes

Market Data Table 1 footnote 1

Changes in inventories may be a result of amounts of dried marijuana sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) is intended for sale, but has not yet been tested/approved; (2) is approved for sale (has been tested and is ready for sale); (3) is intended for extraction activities; or (4) is being held as samples. Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

Return to Market Data Table 1 footnote 1 referrer

Market Data Table 1 footnote 2

Changes in inventories may be a result of amounts of cannabis oil sold, produced, destroyed and imported.

Inventory refers to all cannabis oil held in stock at the end of each quarter. This may include cannabis oil that: (1) is intended for sale, but has not yet been tested/approved; (2) is approved for sale (has been tested and is ready for sale); or (3) is being held as samples. Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

Return to Market Data Table 1 footnote 2 referrer

Market Data Table 1 footnote 3

The MMPR required that health care practitioners include the daily quantity of dried marijuana, expressed in grams, on all medical documents used to register a client. This remains a requirement under the ACMPR. It is the responsibility of each licensed producer to determine the quantity of cannabis oil that is equivalent to one gram of dried marijuana ("the equivalency factor"). Information about the equivalency factor is available on each licensed producer's website.

Return to Market Data Table 1 footnote 3 referrer

Dried Marijuana
Amount sold to clients (kilograms) 4,037 4,773 5,134  5,836
Amount produced (kilograms) 5,014 5,734 N/A N/A
Amount released for sale to clients (kilograms) N/A N/A 4,577  5,674 
Amount in licensed producers' inventories at end of month (kilograms)Market Data Table 1 footnote 1 11,788 13,246 18,087 18,140
Cannabis Oil
Amount sold to clients (kilograms) 1,500 2,420 4,109  5,673 
Amount produced (kilograms) 1,654 3,116 N/A  N/A
Amount released for sale to clients (kilograms) N/A N/A 3,975 5,298
Amount in licensed producers' inventories at end of month (kilograms)Market Data Table 1 footnote 2 2,038 3,330 3,724  5,198 
Client Data
Average amount of dried marijuana for medical purposes authorized per client (grams/day)Market Data Table 1 footnote 3 2.7 2.6 2.5 2.4
Average amount of marijuana for medical purposes per client shipment (grams/day) 0.96 0.89 0.79 0.75
Total number of clients registered at end of quarter 75,166 98,460 129,876  167,754
 
Cannabis for Medical Purposes (FY 2016-17) - Personal and Designated Production: Quarterly Data
  April 1, 2016 to June 30, 2016 (Q1) July 1, 2016 to September 30, 2016 (Q2) October 1, 2016 to December 31, 2016 (Q3) January 1, 2017 to March 31, 2017 (Q4)
Number of Active Registrations
(as of the last day of the reporting period)
Total N/A 192 2,007  3,422
Production for Own Medical Purposes N/A 189 1,899 3,186
Production by Designated Person N/A 3 108  236
 
2015 - 2016 Fiscal Year
April 1, 2015 to June 30, 2015 (Q1) July 1, 2015 to September 30, 2015 (Q2) October 1, 2015 to December 31, 2015 (Q3) January 1, 2016 to March 31, 2016 (Q4)

Table 3 footnotes

Table 3 footnote 1

This refers to the amount of dried marijuana produced that was tested, approved, and ready for sale during each quarter (expressed in kg of dried marijuana).

Return to table 3 footnote 1 referrer

Table 3 footnote 2

Changes in inventories may be a result of amounts of dried marijuana sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) has been dried, but not tested; (2) has been dried and tested, but not approved; or (3) is ready for sale (has been dried, tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

Return to table 3 footnote 2 referrer

Table 3 footnote 3

There were sales of cannabis oil in Q3 by only one licensed producer. As the data is not aggregate sales from multiple licensed producers, the specific amount of cannabis oil sold is being withheld because it is considered confidential business information.

Return to table 3 footnote 3 referrer

Table 3 footnote 4

This refers to the amount of cannabis oil produced that was tested, approved, and ready for sale during each quarter (expressed in kg of cannabis oil).

Return to table 3 footnote 4 referrer

Table 3 footnote 5

Changes in inventories may be a result of amounts of cannabis oil sold, produced, and destroyed.

Inventory refers to all cannabis oil held in stock at the end of each quarter. This may include cannabis oil that: (1) has not been tested; (2) has been tested, but not approved; or (3) is ready for sale (has been tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

Return to table 3 footnote 5 referrer

Table 3 footnote 6

The Marihuana for Medical Purposes Regulations require that health care practitioners include the daily quantity of dried marijuana, expressed in grams, on all medical documents used to register a client. It is the responsibility of each licensed producer to determine the quantity of cannabis oil that is equivalent to one gram of dried marijuana ("the equivalency factor"). Information about the equivalency factor is available on each licensed producer's website.

Return to table 3 footnote 6 referrer

Dried Marijuana
Amount sold to clients (kilograms) 1,371 1,873 2,481 3,082
Amount produced (kilograms)Table 3 footnote 1 1,867 2,142 2,684 4,037
Amount in licensed producers' inventories at end of quarter (kilograms)Table 3 footnote 2 5,445 7,312 9,729 10,695
Cannabis Oil
Amount sold to clients (kilograms) N/A N/A Table 3 footnote 3 584
Amount produced (kilograms)Table 3 footnote 4 N/A 9 128 892
Amount in licensed producers' inventories at end of quarter (kilograms)Table 3 footnote 5 N/A 7 208 1,421
Client Data
Average amount of dried marijuana for medical purposes authorized per client (grams/day)Table 3 footnote 6 3.3 3.0 2.9 2.8
Average amount of marijuana for medical purposes per client shipment (grams/day) 1.08 1.12 1.12 1.03
Total number of clients registered at end of quarter 23,930 30,537 39,668 53,649
 

MMPR Market Data - Dried Marijuana (2015-2016)

Graph of the data from the preceding table

Changes in inventories may be a result of amounts of dried marijuana sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) has been dried, but not tested; (2) has been dried and tested, but not approved; or (3) is ready for sale (has been dried, tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

MMPR Market Data - Cannabis Oil (2015-2016)Footnote a

Graph of the data from the preceding table

Please note that changes in inventories may be a result of amounts of cannabis oil sold, produced, and destroyed.

Inventory refers to all cannabis oil held in stock at the end of each quarter. This may include cannabis oil that: (1) has not been tested; (2) has been tested, but not approved; or (3) is ready for sale (has been tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

2014 - 2015 Fiscal Year

Market Data: Marijuana for Medical Purposes
  April 1, 2014 to June 30, 2014 (Q1) July 1, 2014 to September 30, 2014 (Q2) October 1, 2014 to December 31, 2014 (Q3) January 1, 2015 to March 31, 2015 (Q4)

Table 4 footnotes

Table 4 footnote 1

This refers to the amount of dried marijuana produced that was tested, approved, and ready for sale during each quarter (expressed in kg of dried marijuana). The amount does not include cannabis oil.

Return to table 4 footnote 1 referrer

Table 4 footnote 2

Changes in inventories may be a result of amounts of marijuana for medical purposes sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) has been dried, but not tested; (2) has been dried and tested, but not approved; or (3) is ready for sale (has been dried, tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

Return to table 4 footnote 2 referrer

Amount of dried marijuana sold to clients (kilograms) 408 596 789 979
Amount of dried marijuana produced during quarter (kilograms)Table 4 footnote 1 1,020 1,435 1,809 1,618
Amount of dried marijuana for medical purposes in licensed producers' inventories at end of quarter (kilograms)Table 4 footnote 2 1,134 2,021 2,994 4,667
Average amount of marijuana for medical purposes authorized per client (grams/day) 4 4 4 4
Average amount of marijuana for medical purposes per client shipment (grams/day) 1 1 1 1
Total number of clients registered at end of quarter 7,914 12,409 15,545 18,512
 

MMPR Market Data (2014-2015)

Graph of the data from the first three rows of the preceding table
Report a problem or mistake on this page
Please select all that apply:

Privacy statement

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: